Karlsen TH - Search Results

1

Update on primary sclerosing cholangitis.

Karlsen TH, Boberg KM. Karlsen TH, et al. J Hepatol. 2013 Sep;59(3):571-82. doi: 10.1016/j.jhep.2013.03.015. Epub 2013 Apr 18. J Hepatol. 2013. PMID: 23603668 Free article. Review.

2

Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.

Bowlus CL, Karlsen TH, Broomé U, Thorsby E, Vatn M, Schrumpf E, Lie BA, Boberg KM. Bowlus CL, et al. Among authors: karlsen th. J Hepatol. 2006 Nov;45(5):704-10. doi: 10.1016/j.jhep.2006.03.012. Epub 2006 Apr 25. J Hepatol. 2006. PMID: 16750586

3

Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.

Karlsen TH, Lie BA, Frey Frøslie K, Thorsby E, Broomé U, Schrumpf E, Boberg KM. Karlsen TH, et al. Gastroenterology. 2006 Sep;131(3):781-7. doi: 10.1053/j.gastro.2006.05.057. Gastroenterology. 2006. PMID: 16952547

4

Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM. Karlsen TH, et al. Am J Gastroenterol. 2007 Jan;102(1):115-21. doi: 10.1111/j.1572-0241.2006.00928.x. Epub 2006 Nov 13. Am J Gastroenterol. 2007. PMID: 17100974

5

Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.

Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA. Karlsen TH, et al. J Hepatol. 2007 May;46(5):899-906. doi: 10.1016/j.jhep.2007.01.032. Epub 2007 Feb 27. J Hepatol. 2007. PMID: 17383044

6

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.

Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA. Melum E, et al. Among authors: karlsen th. Hepatology. 2008 Jan;47(1):90-6. doi: 10.1002/hep.21964. Hepatology. 2008. PMID: 18023027

7

An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis.

Melum E, Karlsen TH, Bergquist A, Schrumpf E, Boberg KM. Melum E, et al. Among authors: karlsen th. Am J Gastroenterol. 2008 Apr;103(4):1045; author reply 1045-6. doi: 10.1111/j.1572-0241.2007.01772_5.x. Am J Gastroenterol. 2008. PMID: 18397431 No abstract available.

8

Gallbladder polyps in primary sclerosing cholangitis: not so benign.

Karlsen TH, Schrumpf E, Boberg KM. Karlsen TH, et al. Curr Opin Gastroenterol. 2008 May;24(3):395-9. doi: 10.1097/MOG.0b013e3282f5727a. Curr Opin Gastroenterol. 2008. PMID: 18408471 Review.

9

Genome-wide association studies reach hepatology.

Karlsen TH. Karlsen TH. J Hepatol. 2009 Jun;50(6):1278-80. doi: 10.1016/j.jhep.2009.03.002. Epub 2009 Mar 20. J Hepatol. 2009. PMID: 19395112 No abstract available.

10

Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma.

Forsbring M, Vik ES, Dalhus B, Karlsen TH, Bergquist A, Schrumpf E, Bjørås M, Boberg KM, Alseth I. Forsbring M, et al. Among authors: karlsen th. Carcinogenesis. 2009 Jul;30(7):1147-54. doi: 10.1093/carcin/bgp118. Epub 2009 May 14. Carcinogenesis. 2009. PMID: 19443904 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page